标题
CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 137, Issue 1, Pages 116-126
出版商
Wiley
发表日期
2014-11-29
DOI
10.1002/ijc.29366
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Elimination of IL-10-Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity
- (2014) D. L. Cecil et al. CANCER RESEARCH
- T-Cell-Receptor-Dependent Signal Intensity Dominantly Controls CD4+ T Cell Polarization In Vivo
- (2014) Nicholas van Panhuys et al. IMMUNITY
- Essentials of Th17 cell commitment and plasticity
- (2013) P. Muranski et al. BLOOD
- A Randomized Phase II Trial of Multiepitope Vaccination with Melanoma Peptides for Cytotoxic T Cells and Helper T Cells for Patients with Metastatic Melanoma (E1602)
- (2013) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- Lack of expression of an alternative CD20 transcript variant in circulating B cells from patients with pemphigus
- (2013) Clémentine Gamonet et al. EXPERIMENTAL DERMATOLOGY
- Nonclassical Antigen-Processing Pathways Are Required for MHC Class II-Restricted Direct Tumor Recognition by NY-ESO-1-Specific CD4+ T Cells
- (2013) J. Matsuzaki et al. Cancer Immunology Research
- Analysis of innate and acquired resistance to anti-CD20 antibodies in malignant and nonmalignant B cells
- (2013) George W. Small et al. PeerJ
- High frequency of T cells specific for cryptic epitopes in melanoma patients
- (2013) Rikke Sick Andersen et al. OncoImmunology
- Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms
- (2012) Lixin Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells
- (2012) Ilseyar Akhmetzyanova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human TH17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN- -Secreting Cells as They Differentiate into Effector T Cells In Vivo
- (2012) A. Hamai et al. CANCER RESEARCH
- Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- Splicing in oncogenesis and tumor suppression
- (2012) Daisuke Kaida et al. CANCER SCIENCE
- Universal Cancer Peptide-Based Therapeutic Vaccine Breaks Tolerance against Telomerase and Eradicates Established Tumor
- (2012) M. Dosset et al. CLINICAL CANCER RESEARCH
- Analysis of Spontaneous Tumor-Specific CD4 T-cell Immunity in Lung Cancer Using Promiscuous HLA-DR Telomerase-Derived Epitopes: Potential Synergistic Effect with Chemotherapy Response
- (2012) Y. Godet et al. CLINICAL CANCER RESEARCH
- The Cancer Exome Generated by Alternative mRNA Splicing Dilutes Predicted HLA Class I Epitope Density
- (2012) Thomas Stranzl et al. PLoS One
- Identification of an alternative CD20 transcript variant in B-cell malignancies coding for a novel protein associated to rituximab resistance
- (2010) C. Henry et al. BLOOD
- CD4+ T-Cell Help in the Tumor Milieu Is Required for Recruitment and Cytolytic Function of CD8+ T Lymphocytes
- (2010) R. Bos et al. CANCER RESEARCH
- Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors
- (2010) Jinfang Zhu et al. IMMUNOLOGICAL REVIEWS
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
- (2009) F. M. Speetjens et al. CLINICAL CANCER RESEARCH
- Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients
- (2009) Jun-ichi Kobayashi et al. Journal of Translational Medicine
- ASTD: The Alternative Splicing and Transcript Diversity database
- (2008) Gautier Koscielny et al. GENOMICS
- Multiple roles for CD4+T cells in anti-tumor immune responses
- (2008) Richard Kennedy et al. IMMUNOLOGICAL REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started